+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Herantis Pharma plc - logo

Herantis Pharma is a specialty pharmaceutical company based in Helsinki, Finland. It specializes in drugs for the treatment of dry eye, Parkinson's diseases, amyotrophic lateral sclerosis (ALS) and secondary lymphedema. They are developing selected drug candidates through late preclinical and early clinical stages. Herantis products in pipeline include Cis-UCA eye drops, CDNF for the treatment of Parkinson's Diseases ALS; and Lymfactin, which is in clinical trials for treating breast cancer.

From
From
From
Bladder Cancer Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Bladder Cancer Treatment Market Report and Forecast 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
From
Alpha Mannosidosis Global Market Report 2024 - Product Thumbnail Image

Alpha Mannosidosis Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Lymphoedema - Pipeline Insight, 2024 - Product Thumbnail Image

Lymphoedema - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
  • 10 Results (Page 1 of 1)
Loading Indicator